Renaissance Technologies’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $242M | Buy |
504,668
+38,760
| +8% | +$19.8M | 0.38% | 30 |
|
|
2025
Q4 | $262M | Sell |
465,908
-27,680
| -6% | -$15.7M | 0.41% | 36 |
|
|
2025
Q3 | $254M | Sell |
493,588
-184,500
| -27% | -$80.6M | 0.34% | 47 |
|
|
2025
Q2 | $213M | Buy |
678,088
+100,400
| +17% | +$30.1M | 0.28% | 59 |
|
|
2025
Q1 | $176M | Buy |
577,688
+24,100
| +4% | +$8.11M | 0.27% | 62 |
|
|
2024
Q4 | $184M | Buy |
553,588
+61,100
| +12% | +$20.7M | 0.27% | 56 |
|
|
2024
Q3 | $164M | Buy |
492,488
+48,900
| +11% | +$18.6M | 0.25% | 70 |
|
|
2024
Q2 | $183M | Buy |
443,588
+122,800
| +38% | +$48.6M | 0.31% | 53 |
|
|
2024
Q1 | $130M | Buy |
320,788
+69,400
| +28% | +$24.4M | 0.2% | 97 |
|
|
2023
Q4 | $77.1M | Sell |
251,388
-7,800
| -3% | -$2.11M | 0.12% | 191 |
|
|
2023
Q3 | $62.8M | Buy |
259,188
+48,300
| +23% | +$12.4M | 0.11% | 199 |
|
|
2023
Q2 | $50.6M | Sell |
210,888
-86,600
| -29% | -$18M | 0.07% | 312 |
|
|
2023
Q1 | $55.9M | Buy |
297,488
+93,500
| +46% | +$19.3M | 0.07% | 324 |
|
|
2022
Q4 | $43.3M | Sell |
203,988
-62,200
| -23% | -$12.4M | 0.06% | 385 |
|
|
2022
Q3 | $41.8M | Sell |
266,188
-88,700
| -25% | -$14.2M | 0.06% | 371 |
|
|
2022
Q2 | $53.1M | Sell |
354,888
-25,200
| -7% | -$3.65M | 0.06% | 349 |
|
|
2022
Q1 | $62.2M | Sell |
380,088
-14,800
| -4% | -$2.44M | 0.07% | 286 |
|
|
2021
Q4 | $85.9M | Sell |
394,888
-19,000
| -5% | -$3.98M | 0.11% | 209 |
|
|
2021
Q3 | $78.3M | Sell |
413,888
-8,400
| -2% | -$1.53M | 0.1% | 210 |
|
|
2021
Q2 | $74.6M | Sell |
422,288
-42,100
| -9% | -$7.27M | 0.09% | 224 |
|
|
2021
Q1 | $76.2M | Sell |
464,388
-139,400
| -23% | -$21.3M | 0.09% | 224 |
|
|
2020
Q4 | $84M | Sell |
603,788
-234,300
| -28% | -$29.5M | 0.09% | 224 |
|
|
2020
Q3 | $93.7M | Sell |
838,088
-35,332
| -4% | -$4.09M | 0.09% | 228 |
|
|
2020
Q2 | $81.2M | Buy |
873,420
+53,732
| +7% | +$4.57M | 0.07% | 308 |
|
|
2020
Q1 | $60.1M | Buy |
819,688
+233,600
| +40% | +$20.3M | 0.06% | 334 |
|
|
2019
Q4 | $49.3M | Buy |
586,088
+112,100
| +24% | +$8.68M | 0.04% | 529 |
|
|
2019
Q3 | $39.8M | Buy |
473,988
+130,888
| +38% | +$9.89M | 0.03% | 586 |
|
|
2019
Q2 | $22.4M | Buy |
343,100
+101,000
| +42% | +$5.82M | 0.02% | 907 |
|
|
2019
Q1 | $14.3M | Sell |
242,100
-246,400
| -50% | -$14.7M | 0.01% | 1164 |
|
|
2018
Q4 | $25.9M | Sell |
488,500
-296,400
| -38% | -$16.3M | 0.03% | 743 |
|
|
2018
Q3 | $47M | Buy |
784,900
+446,000
| +132% | +$24.4M | 0.05% | 466 |
|
|
2018
Q2 | $14.6M | Buy |
338,900
+229,200
| +209% | +$9.26M | 0.02% | 1129 |
|
|
2018
Q1 | $3.83M | Sell |
109,700
-73,800
| -40% | -$2.7M | ﹤0.01% | 1990 |
|
|
2017
Q4 | $6.65M | Buy |
183,500
+98,400
| +116% | +$3.45M | 0.01% | 1630 |
|
|
2017
Q3 | $2.71M | Buy |
+85,100
| New | +$2.6M | ﹤0.01% | 2125 |
|
Other funds holding MEDP
VPM
VCM
WA
Renaissance Technologies's MEDP Position: Q1 2026 in Review
Renaissance Technologies increased its Medpace (MEDP) stake by 8.3% in Q1 2026, buying an estimated $19.8M and bringing the position to 504,668 shares worth $242M. The position accounts for 0.38% of the portfolio, ranked #30.
Renaissance Technologies first reported a position in MEDP in Q3 2017 and has held it in 35 quarters since. The position peaked at $262M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Renaissance Technologies held 504,668 shares of Medpace worth $242M as of Q1 2026.
- Renaissance Technologies bought 38,760 Medpace shares in Q1 2026, an estimated $19.8M.
- Medpace made up 0.38% of Renaissance Technologies's portfolio in Q1 2026, its #30 holding.
- Renaissance Technologies first reported a position in Medpace in Q3 2017 and has held it in 35 quarters since.
- Renaissance Technologies's Medpace position peaked at $262M in Q4 2025.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.